Article Information
History
- September 14, 2020.
Article Versions
- Version 1 (July 17, 2020 - 17:03).
- Version 2 (July 21, 2020 - 08:42).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- A. Sofia F. Oliveiraa,
- Amaurys Avila Ibarrab,
- Isabel Bermudezc,
- Lorenzo Casalinod,
- Zied Gaiebd,
- Deborah K. Shoemarke,
- Timothy Gallaghera,
- Richard B. Sessionse,
- Rommie E. Amarod and
- Adrian J. Mulhollanda,*
- aCentre for Computational Chemistry, School of Chemistry, University of Bristol, Bristol BS8 1TS, UK
- bResearch Software Engineering, Advanced Computing Research Centre, University of Bristol, Bristol BS1 5QD, UK
- cDepartment of Biological and Medical Sciences, Oxford Brookes University, Oxford OX30BP, UK
- dDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093 USA
- eSchool of Biochemistry, University of Bristol, Bristol BS8 1DT, UK
- ↵*Corresponding author(s): adrian.mulholland{at}bristol.ac.uk
Posted September 14, 2020.
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors
